Cognitive Behavioral Therapy for Suicidal Thoughts in Older Adults
(ANSWERS-OA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) can reduce suicidal thoughts in older adults with insomnia. Researchers aim to determine if better sleep can also enhance mental health in this group. Two groups will participate: one will receive immediate therapy, while the other will be on a waitlist before receiving therapy. This trial is best suited for English-speaking individuals aged 55 and older who have recently experienced suicidal thoughts and are dealing with ongoing insomnia. As an unphased trial, participants can contribute to groundbreaking research that may improve mental health treatments for older adults.
Will I have to stop taking my current medications?
If you are taking psychotropic medications (like antidepressants or sleep aids), you must not have changed the dose in the past 6 weeks and agree not to change it during the trial. If you are not on such medications, you need to be medication-free for at least 6 weeks before starting the trial and agree not to start any new medications during the trial.
What prior data suggests that digital Cognitive Behavioral Therapy for Insomnia is safe for older adults?
Research shows that digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) is safe and well-tolerated by older adults. Studies have found that it effectively reduces insomnia symptoms without causing significant side effects. Unlike medications, this behavioral treatment usually avoids the side effects drugs might cause. Additionally, studies combining results from multiple research projects confirm the safety and lasting benefits of CBT-I for older adults. Therefore, evidence suggests that dCBT-I is a safe option for treating insomnia and may also help improve suicidal thoughts in this age group.12345
Why are researchers excited about this trial?
Researchers are excited about digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) because it offers a unique approach to addressing suicidal thoughts in older adults by targeting insomnia, a significant risk factor. Unlike traditional therapies, which might involve medications or face-to-face sessions, dCBT-I is delivered online via a program called Sleep Healthy Using the Internet (SHUTi), making it accessible and convenient for users. This digital format allows for personalized, self-paced treatment, which can be especially beneficial for older adults who may have mobility issues or prefer the privacy of home-based therapy. By directly addressing insomnia, researchers hope to indirectly reduce suicidal ideation, providing a holistic approach to mental health care.
What evidence suggests that digital Cognitive Behavioral Therapy for Insomnia might be an effective treatment for suicidal thinking in older adults?
Research has shown that Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I), which participants in this trial may receive, effectively reduces insomnia and improves sleep quality in older adults. One study found that using dCBT-I to treat insomnia can help reduce and prevent suicidal thoughts, which is crucial since insomnia can increase the risk of such thoughts. Additionally, dCBT-I has improved symptoms of anxiety and depression in people aged 65 and older. These findings suggest that dCBT-I might be a valuable tool for reducing suicidal thoughts by enhancing sleep and mental health in older adults. Participants in the waitlist control group will initially undergo monitoring before receiving dCBT-I.678910
Who Is on the Research Team?
Michael A Grandner, PhD
Principal Investigator
University of Arizona
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals aged 65 or older with insomnia and recent suicidal thoughts. They must be willing to share information between the research team and their mental health provider, not work night shifts, have internet access, and not plan to change psychotropic medications during the trial.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 8 weeks of digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) or are placed in a waitlist control group with weekly monitoring
Crossover Treatment
Participants in the waitlist control group crossover to receive 8 weeks of dCBT-I, while those initially receiving dCBT-I undergo active monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6- and 12-months post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Digital Cognitive Behavioral Therapy for Insomnia
Trial Overview
The study tests digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) in older adults to see if it reduces suicidal thinking. It's a preliminary investigation into whether treating sleep problems can help alleviate suicide risk factors without necessarily improving cognition.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Following baseline evaluation, participants in this group will receive 8 weeks of digital Cognitive Behavioral Therapy for Insomnia delivered using Sleep Healthy Using the Internet (SHUTi). After the interim assessment, participants will then crossover to 8 weeks of active monitoring.
Following baseline evaluation, participants in this group will undergo weekly monitoring of insomnia and suicidal ideation for 8 weeks. Participants will continue whatever treatments they are currently receiving, but will receive no specific instructions or behavioral interventions for insomnia. After the interim assessment, participants will then crossover to receive digital Cognitive Behavioral Therapy for Insomnia.
Digital Cognitive Behavioral Therapy for Insomnia is already approved in United States, European Union, Canada for the following indications:
- Insomnia
- Suicidal ideation
- Insomnia
- Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
MICHAEL A GRANDNER
Lead Sponsor
University of Pennsylvania
Collaborator
Published Research Related to This Trial
Citations
Cognitive-behavioral therapy for insomnia prevents and ...
Our trial showed that treating insomnia to remission with digital CBTI alleviates and prevents suicidal ideation. This study is the first to support treating ...
NCT04986007 | Addressing Nocturnal Sleep/Wake Effects ...
Consequently, this study will help inform future study designs and provide preliminary data on whether dCBT-I is effective for suicidal thinking in older adults ...
Efficacy of digital cognitive behavioral therapy for treating ...
Conclusion: dCBT can effectively improve symptoms of insomnia, anxiety, and depression in adults aged 65+. Digital CBT may serve as an accessible means for ...
Combined Dialectical Behavior Therapy and Digital ...
The goal of this clinical trial is to learn providing insomnia treatment in conjunction with suicide-focused treatment leads to greater reductions in ...
Cognitive Behavioral Therapy for Suicidal Thoughts in ...
Research shows that Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) is effective in reducing insomnia severity, improving sleep quality, and ...
A randomized controlled trial of a digital cognitive ...
Meta-analyses support CBT-I as efficacious and safe, with long-lasting effects in older adults. As a behavioral rather than pharmacological ...
A randomized controlled trial of a digital cognitive ...
Results indicate that digital CBT-I provides important benefits for older adults, offering strong potential to expand access to insomnia ...
0352 Digital cognitive behavioral therapy in treating insomnia ...
Digital CBT led to significantly greater improvements at post-treatment and follow-up relative to control for the combined sleep (ds≤-1.34, ps<.
Digital Sleep Therapy for Older Adults with Cognitive ...
This study aims to determine the efficacy of digital Behavioural Therapy for Insomnia (dBTi) compared to online sleep health education (control) at reducing ...
main outcomes of a randomized dismantling trial
All groups exhibited insomnia symptom reduction at posttreatment (CT: d = −2.53, P < .001; BT: d = −2.39, P < .001; CBT: d = −2.90, P < .001) ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.